Tumor marker tests revealed an AFP level of 185.4 ng/ml, while squamous cell carcinoma-related antigen, cancer antigen 125 (CA125), and prostate-specific antigen (PSA) were within normal ranges. This evidence concerns the gene AFP and neoplasm.